Literature DB >> 3202967

Cysteine and metalloproteinase activities in serum of Duchenne muscular dystrophic genotypes.

I Sohar1, A Laszlo, K Gaal, F Mechler.   

Abstract

Lysosomal cysteine proteinase (cathepsin B, H, and L) and MMP-7ase muscle metalloproteinase activities were measured in serum from Duchenne muscular dystrophic male patients and their mothers as gene-carriers. The activity of cathepsin H significantly increased in the Duchenne muscular dystrophic (DMD)-hemizygotes group and in the group of DMD heterozygotes. Significant positive correlation was found between the activity of serum creatine kinase (which previously has been proven to be a marker of muscular dystrophy) and of cathepsin L in the DMD-hemizygotes group. Furthermore, correlations were found between the activity of creatine kinase and MMP-7ase or between activity of creatine kinase and cathepsin H in the DMD heterozygotes. The changes in activity of proteolytic enzymes in serum of dystrophic patients can be explained by the elevated proteolytic enzyme activity in dystrophic muscle observed previously.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3202967

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  6 in total

1.  Regulation of TIMP-2, MT1-MMP, and MMP-2 expression during C2C12 differentiation.

Authors:  Gentian Lluri; Diane M Jaworski
Journal:  Muscle Nerve       Date:  2005-10       Impact factor: 3.217

2.  Demonstration of cathepsins B, H and L in xenografts of normal and Duchenne-muscular-dystrophy muscles transplanted into nude mice.

Authors:  A Takeda; T Jimi; Y Wakayama; N Misugi; S Miyake; T Kumagai
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

Review 3.  Cystatin C in aging and in Alzheimer's disease.

Authors:  Paul M Mathews; Efrat Levy
Journal:  Ageing Res Rev       Date:  2016-06-19       Impact factor: 10.895

Review 4.  Protective mechanisms by cystatin C in neurodegenerative diseases.

Authors:  Sebastien Gauthier; Gurjinder Kaur; Weiqian Mi; Belen Tizon; Efrat Levy
Journal:  Front Biosci (Schol Ed)       Date:  2011-01-01

Review 5.  Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy.

Authors:  Yuji Ogura; Marjan M Tajrishi; Shuichi Sato; Sajedah M Hindi; Ashok Kumar
Journal:  Front Cell Dev Biol       Date:  2014-04-01

Review 6.  Neo-epitope Peptides as Biomarkers of Disease Progression for Muscular Dystrophies and Other Myopathies.

Authors:  A Arvanitidis; K Henriksen; M A Karsdal; A Nedergaard
Journal:  J Neuromuscul Dis       Date:  2016-08-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.